Salivary Gland Tumors: A 20 Year Review From a Single Community Practice
Ear, Nose & Throat Journal · 2026
DOI: 10.1177/01455613241233085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ear, Nose & Throat Journal, 2026. Verfasst von Emily Smith und 2 weiteren Autor:innen. Beteiligte Einrichtung: Tufts University School of Medicine, Boston, MA, USA. Hauptthemen laut MEDLINE: Salivary Gland Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Salivary gland tumors are a heterogenous group of lesions with variable pathology and clinical outcomes. Most published data are derived from studies conducted at tertiary care centers. Our study analyzed the experience from a community setting to determine significant differences, if any, in pathological distribution and clinical outcomes compared to the existing literature.
Methods
We performed a retrospective analysis of all major salivary gland tumors that presented to a large community practice over a 20 year period. Retrospective chart analysis was performed for demographics, clinical presentation, imaging, cytology, histopathology, and clinical outcome data.
Results
Of 806 patients, the parotid gland was the most common site in 683 patients (84.7%), followed by submandibular in 78 (9.7%) and sublingual in 45 (5.6%). A total of 203 patients were managed conservatively with observation without definitive diagnosis or lost to follow-up. A total of 495 patients underwent surgical intervention within the community practice. Twenty-six patients underwent surgical excision at an outside hospital. Eighty-two patients were determined to have a benign diagnosis based on ultrasound-guided fine needle aspiration or excisional biopsy alone. Final histopathology was benign in 505 cases (83.7%), while 98 tumors (16.3%) received a diagnosis of primary or secondary malignancy. For the parotid gland, pleomorphic adenoma (155) and Warthin’s tumor (155) were the most common benign diagnoses, while mucoepidermoid carcinoma (13), adenocarcinoma (8), and acinic cell carcinoma (8) were the most common primary malignancies.
Conclusions
We found a higher rate of benign tumor pathology compared to the existing literature. While the outcome data on surgical treatment of benign tumors are comparable to the existing literature, the same conclusion cannot be drawn for malignant tumors, given relatively small numbers in our series and likely disparity in the complexity of the surgical cases in tertiary care centers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tufts University School of Medicine, Boston, MA, USA.
- University of Massachusetts T. H. Chan Medical School, Worcester, MA, USA.
- Department of Otolaryngology-Head and Neck Surgery, Tufts Medical Center, Boston, MA.
- ENT Specialists, Inc., Brockton, MA, USA.
ORCID-Profile: Emily Smith, Christopher Zaro
Zitieren
APA
Smith, E., Zaro, C., & Dhingra, J. K. (2026). Salivary Gland Tumors: A 20 Year Review From a Single Community Practice. Ear, Nose & Throat Journal. https://doi.org/10.1177/01455613241233085
Vancouver
Smith E, Zaro C, Dhingra JK. Salivary Gland Tumors: A 20 Year Review From a Single Community Practice. Ear, Nose & Throat Journal. 2026. doi:10.1177/01455613241233085
BibTeX
@article{Smith2026,
author = {Smith, Emily and Zaro, Christopher and Dhingra, Jagdish K},
title = {Salivary Gland Tumors: A 20 Year Review From a Single Community Practice},
journal = {Ear, Nose & Throat Journal},
year = {2026},
doi = {10.1177/01455613241233085}
}
EUVIMED